Breast cancer screening for women aged 45 - 49 years - what does the evidence mean for New Zealand?
Reviewing the evidence on the benefits, harms and costs of breast cancer screening for women aged 40 to 49 years in New Zealand.
© Crown Copyright, Attribution 4.0 International (CC BY 4.0)
Reviewing the evidence on the benefits, harms and costs of breast cancer screening for women aged 40 to 49 years in New Zealand. Simon Baker, Madeleine Wall, Ashley Bloomfield The New Zealand Medical Journal. Vol 118 No1221 ISSN1175 8716
- what does the evidence mean for New Zealand?